Article
A case of advanced biliary tract cancer with EGFR amplification that responded to Necitumumab and post-treatment resistance changes detected by liquid biopsy
2024-03-31
Abstract excerpt
<h4>Background: </h4> Recent advances in cancer genome analysis and the practice of precision medicine have made it possible to identify fractions with rare genetic alterations. EGFR -amplified cancers are known to be rare fractions across organs and have a poor prognosis. The use of anti-EGFR antibody for EGFR -amplified cancers has been promising, but the evidence is not yet clear. Case: In this report, we de...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2eb69c65-8fb5-500d-b1d7-949c10382145
- DOI
- 10.22541/au.171189338.87013934/v1
